Identification of a β-1,3-N-acetylgalactosaminyltransferase (CGTE) from Campylobacter jejuni LIO87
AssigneeNational Research Council of Canada
InventorsMichel Gilbert, Warren Wakarchuk, Scott Houliston
Life of this patent
Estimating the term…
Abstract
The invention relates to β-1,3-N-acetylgalactosaminyltransferase polypeptides, nucleic acids that encode the polypeptides, and methods of using the polypeptides.
Claims15
A composition comprising an isolated or recombinant β-1,3-N-acetylgalactosaminyltransferase polypeptide, a donor substrate comprising the galactose moiety GalNAc, and an acceptor substrate comprising a terminal galactose residue wherein the β-1,3-N-acetylgalactosaminyltransferase polypeptide comprises an amino acid sequence with at least 95% identity to the full length of SEQ ID NO:2, and wherein the β-1,3-N-acetylgalactosaminyltransferase polypeptide transfers the galactose moiety from a donor substrate to an acceptor substrate.
A method of producing a galactosylated product saccharide, the method comprising the step of:
- a. contacting an acceptor substrate comprising a terminal galactose residue with a donor substrate comprising a GalNAc galactose moiety and an isolated or recombinant β-1,3-N-acetylgalactosaminyltransferase polypeptide with at least 95% identity to SEQ ID NO:2;
- and
- b. allowing transfer of a galactose moiety to the acceptor saccharide to occur, thereby producing the galactosylated product saccharide.
Dependencies are inferred from the claim text.